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Anorexia nervosa is one of the earliest psychiatric
illnesses to be described in the medical literature with
well documented accounts made in the 19th century by
both Gull [1] and Lasègue [2]. They both expressed
optimism about the eventual outcome of treatment.
Since then, there have been many claims about success-
ful outcomes, but all too often only reversal of the
undernourished state is achieved [3]. Treatment may
have minimal impact on the persistent and unrelenting
ruminations pertaining to food, shape and weight which
are so characteristic of those with SE-AN. Good progress
has been made in treating younger patients with a
shorter duration of illness using family-based approaches
[4, 5] but it is those who either fail to respond, or go on
to develop a severe and enduring form of the disorder
(SE-AN), that have received little or no attention to date [6].
Those living with a chronic illness, especially one as
debilitating as SE-AN, are entitled to dream of a better
tomorrow and to feel understood not only by the
medical profession but by the world at large [7]. Almost
every day, we are reminded about the extra-ordinary
breakthroughs being made in the fight against cancer,
whilst we continue to battle over the vexed issues of the
imposition of involuntary treatment and the ethics of
palliative care. Patients with SE-AN can no longer be
ignored for they have suffered for far too long, having to
contend with an abysmal quality of life devoid of any
hope of an effective treatment on the horizon. This situ-
ation is in urgent need of address especially since there has
only been one randomised controlled trial to date [8] that
has specifically focussed upon those with the severe and
enduring form of the illness. Much more needs to be done.
The time has now arrived to take the bold step in recon-
ceptualising illness severity in anorexia nervosa especially
since there is a growing recognition that the factors that
may contribute towards its onset are not necessarily the
same as the ones that may perpetuate it [9]. Our current
classification system (DSM-5), although an improvement
over its predecessors, remains limited in its clinical utility
especially when identifying the onset of illness (when
treatment is most likely to be effective) and giving special
recognition to those when it becomes persistent [10, 11].
We have provided a cogent argument that a clinical staging
model, that is so widespread in the conceptualisation
and treatment of somatic illness, be adopted in anorexia
nervosa. Such a model has been applied in malignancies,
cardiac failure, auto-immune disease and burns where both
prognosis and treatment are informed by stage [12]. An-
orexia nervosa is ideally suited for the adoption of a staging
model, because unlike any other psychiatric disorder, it has
clearly delineated physical biomarkers of disease progres-
sion, for example bradycardia and raised liver enzymes [13]
Like so many illnesses, anorexia nervosa exists on a
spectrum. Just as there is no single treatment advo-
cated for all cancers, there should not only be one
treatment for all patients with anorexia nervosa. It is
clear that a 14 year old adolescent with a 3 month
history of anorexia nervosa would present differently
to a 40 year old woman who has battled the illness
for 25 years with multiple hospital admissions and
has attempted cognitive behaviour therapy several
times. Those with SE-AN are more likely to have
high levels of disability, to be under- or unemployed,
to be receiving welfare, supported by health benefit
plans and become a significant burden to family,
carers and health fund providers. In fact on measures
such as quality of life, those with SE-AN have been
found to be equal in impairment to those with severe
depressive disorder as well as schizophrenia [14]. Such
factors provide a compelling argument as to why a re-
habilitation model of care, not too dissimilar to the ones
advocated for those with schizophrenia, needs to be
considered for those with a persistent eating disorder in-
cluding highly specialised acute care when the need arises.
It goes without saying that such patients with SE-AN
are amongst the most challenging found in mental
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health care [15]. They have a markedly reduced life ex-
pectancy with the highest mortality rate of any mental
illness (at 20 years the mortality rate is 20 %). Because
the onset of anorexia nervosa occurs at a young age, it is
unfortunately not uncommon for death to occur in
young adults in their thirties with a further 5-10 % every
decade thereafter [16]. They suffer from a myriad of
medical complications and are frequent but often reluc-
tant visitors to general and specialist medical facilities as
well as primary care services [6].
Most patients with SE-AN are unlikely to fully recover.
Some do but they are in the minority. It is therefore
extremely important not to focus solely upon symptom
reduction, but to also take into account a more holistic
model of care. Such a’ recovery model’ needs to take
cognisance of the person as a whole by improving not
only quality of life, but overall general functioning,
employment and access to suitable housing as well [17].
This requires that our more traditional approaches to
treatment, developed for earlier stages of severity,
undergo a metamorphosis to better fit the needs of those
with a chronic and often unrelenting illness [18].
In a recent randomised controlled trial we attempted
to capitalise on those principles advocated by the ‘re-
covery model’ by comparing two psychological treat-
ments which were specifically adapted for those with a
more chronic disorder (Cognitive Behaviour Therapy
(CBT-SE) and Specialist Supportive Clinical Manage-
ment (SSCM-SE)) [8]. The hallmark and defining fea-
ture of this study, was that for the first time symptom
reduction was not designated as a primary outcome
measure. Weight gain was actively promoted but the
primary goal was an enhanced quality of life. Both treat-
ment arms were successful in promoting change and by
the 12th month follow-up period, those patients receiv-
ing CBT-SE had lower Eating Disorders Examination
global scores as well as a higher readiness to recover
than those receiving SSCM-SE. However, the standout
feature was the remarkably low treatment attrition rate
of 13 % [19] which to our knowledge is one of the low-
est ever reported. We need to rethink our treatment
strategies by drawing upon the patient’s strengths and
competencies rather than merely paying attention to
what is ‘wrong’ with them. Undertaking treatment with a
poorly motivated, chronically ill patient where loneliness,
despair and an empty sense of self prevail, poses unique
challenges for clinicians. As Strober [15] has cautioned,
such a therapeutic endeavour requires a temperament
capable of enduring hours of “…sameness, respect for
solitude, the ability to face frailty and profound sickness
with relative ease and the ability and willingness to explore
the wounds and deprivation of a life passed by”. It is also
so important to never lose the sense of hope as some
(albeit few) go on to make a complete recovery.
Because of the plight of those afflicted with SE-AN
[20], researchers and clinicians are now pushing the
frontiers of science by exploring new and bold avenues
of investigation such as deep brain stimulation [18, 21]
and transcranial magnetic stimulation [18, 22]. As we
delve into this brave new world, it is important not lose
sight of the first rule of medicine - primum non nocere.
Some people with SE-AN are so desperate to seek relief
for their untold misery that they will agree to almost
anything that promises relief from their suffering and
despair. The ethical debate has already begun as to
whether interventions such as deep brain stimulation is
in fact offering hope to the hopeless or merely exploiting
the vulnerable [23].
There is now more than ever before a compelling need
to bring such new ideas and emerging data to the fore in
a timely fashion so that replication of the most promis-
ing new data can occur and the ethical considerations
widely debated. The wheel may have already started to
turn with a plenary session debating this issue at the
next Eating Disorder Research Society Meeting [24] in
Sicily in September. Furthermore, this journal (Journal
of Eating Disorders) plans to publish a special issue en-
tirely dedicated to those patients not only with anorexia
nervosa (SE-AN), but those falling within the broader
spectrum of eating disorders as well. It is hoped that
such a special issue focussing entirely upon those with a
persistent eating disorder will not only draw attention to
this long-suffering group, but also generate new avenues
of exploration as well.
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